When I compare the battering of our SP in the face of some very impressive clinical data and a broad pipeline to the shorting of the stock, I no longer scratch my head. And, the fact that the rapid increase from the same nominal amount throughout the entire year until the day that the CR shares were issued, suggests to me that those investors/traders would be wanting to buy back those shares cheap... and as cheap as possible.
Chimeric: Media Thread, page-610
-
- There are more pages in this discussion • 243 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
